With the notion of science above everything else, a strong tumor research team has been formed, combined with the academic background and interests of the scientists, and concentrated on tackling key tumor science and clinical core issues.
On April 18, 2022, Prof. Huang Gang from University of Texas Health Science Center at San Antonio was invited to attend the ICR Seminar Series. Prof. Huang delivered an outstanding on-line seminar: "Wnt Signaling Potentiators as Novel Canver Immunotherapeutic Targets".
Prof. Hua...
The SZBL Institute of Cancer Research (ICR) on December 12 convened its 2021 annual retreat. More than 70 scientific and administrative staff attended the event onsite or through virtual link. SZBL Director Zhan Qimin was invited to deliver remarks. Professor Zhang Zemin, Head of ICR, chaired the ev...
According to data released by the World Health Organization (WHO), cancer is still a major killer facing humanity in the world today. Cancer is the second leading cause of death around the world, killing approximately 10 million people every year. About one in six deaths worldwide are caused by c...
On May 26, the China Postdoctoral Science Foundation released the result for the 2021 Postdoctoral Support Program for Innovative Talents. A total of 23 young scholars were awarded as innovative personnel in the clinical medicine segment, including Dr. Ding Ning from the Shenzhen Bay Laboratory (SZB...
Recently, the leading science journal Cell has announced its best articles for the year of 2020, which include a study from Professor Zemin Zhang, the lead of the Institute of Cancer Research (ICR) at SZBL and his collaborators. Sixteen science articles were selected for the annual ...
On December 24th and 25th, the Institute of Cancer Research under the Shenzhen Bay Laboratory (hereinafter referred to as the ICR) held a year-end summary meeting (academic annual meeting). More than 50 people made up of all principal investigators and related scientific researchers a...
